Altered folate and vitamin B12 metabolism in families with spina bifida offspring

QJM: An International Journal of Medicine

Volumn 90, Issue 8, 1997, Pages 505-510

  Van Der Put, N M J ^a   Thomas, C M G ^a   Eskes, T K A B ^a   Trijbels, F J M ^a   Steegers Theunissen, R P M ^a   Mariman, E C M ^a   De Graaf Hess, A ^a   Smeitink, J A M ^a   Blom, H J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; 5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; FOLIC ACID; GLYCINE HYDROXYMETHYLTRANSFERASE; HOMOCYSTEINE; METHYLENETETRAHYDROFOLATE DEHYDROGENASE;

ADOLESCENT; ADULT; ARTICLE; CHILD; FEMALE; FOLATE METABOLISM; FOLIC ACID BLOOD LEVEL; GENE MUTATION; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEURAL TUBE DEFECT; PRIORITY JOURNAL; PROGENY; SCHOOL CHILD; SPINA BIFIDA; VITAMIN METABOLISM;

EID: 0030864413     PISSN: 00335622     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/90.8.505     Document Type: Article

References (21)

1. Put van der NMJ, Steegers-Theunissen RPM, Frosst P, et al. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 1995; 346:1071-2.
2. Whitehead AS, Gallagher P, Mills JL, et al. A genetic defect in 5,10-methylenetetrahydrofolate reductase in neural tube defects. Q J Med 1995; 88:763-6.
3. Smithells RW, Sheppard S, Schorah CJ, et al. Possible prevention of neural-tube defects by periconceptional vitamin supplementation. Lancet 1980; 1:339-40.
4. Smithells RW, Sheppard S, Wild J, Schorah CJ. Prevention of neural-tube recurrences in Yorkshire: final report. Lancet 1989; 2:498-9.
5. Laurence KM, James M, Miller MH, Tennant GB, Campbell H. Double-blind randomized controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. Br Med J 1981; 282:1509-11.
6. Vergel RG, Sanchez LR, Hedero BL, Rodriguez PL, Martinez AJ. Primary prevention of neural-tube defects with folic acid supplementation: Cuban experience. Prenat Diagn 1990; 10:149-52.
7. MRC Vitamin study research group. Prevention of neural-tube defects: results of the medical research council vitamin study. Lancet 1991; 338:131-7.
8. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992; 327:1832-5.
9. Put van der NMJ, Heuvel van den LP, Steegers-Theunissen RPM, et al. Decreased methylenetetrahydrofolate reductase function due to the 677C→T mutation in families with Spina Bifida offspring. J Mol Med 1996; 74:691-4.
10. Engbersen AMT, Franken DC, Boers GHJ, Stevens EMB, Trijbels FJM, Blom HJ. Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am J Hum Genet 1995; 56:142-50.
11. Wouters MGAJ, Moorrees MThEC, Van der Mooren MJ, et al. Plasma homocysteine and menopausal status. Eur J Clin Invest. 1995; 25:801-5.
12. TePoele-Pothoff MTWB, VanDenBerg M, Franken DG, et al. Three different methods for the determination of total homocysteine in plasma. Ann Clin Biochem 1995; 32:218-20.
13. Steegers-Theunissen RPM, Boers GHJ, Trijbels FJM, et al. Maternal hyperhomocysteinemia: A risk-factor for neural-tube defects? Metabolism 1994; 43:1475-80.
14. Smithells RW, Sheppard S, Schorah CJ. Vitamin deficiencies and neural tube defects. Arch Dis Childh 1976; 51:944-50.
15. Yates JRW, Ferguson-Smith MA, Shenkin A, Guzman-Rodriguez R, White M, Clark BJ. Is disordered folate metabolism the basis for the genetic predisposition to neural-tube defects? Clin Genet 1987; 31:279-87.
16. Wild J, Seller MJ, Schorah CJ, Smithells RW. Investigations of folate intake and metabolism in women who have had two pregnancies complicated by neural-tube defects. Br J Obstet Gynaecol 1994; 101:197-202.
17. Mills JL, McPartlin JM, Kirke PN, et al. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet 1995; 345:149-51.
18. Kirke PN, Molloy AM, Daly LE, Burke H, Weir DC, Scott JM. Maternal plasma folate and vitamin B12 are independent risk factors for neural-tube defects. Q J Med 1993; 86:703-8.
19. Davis BA, Bailey LB, Gregory III JF, Toth JP, Dean J, Stevenson RE. Folic acid absorption in women with a history of pregnancy with neural tube defect. Am J Clin Nutr 1995; 62:782-4.
20. Finkelstein JD. Methionine metabolism in mammals. J Nutr Biochem 1990; 1:228-37.
21. VanAerts LAGJM, Blom HJ, DeAbreu A, et al. Prevention of neural tube defects by and toxicity of L-homocysteine in cultured postimplantation rat embryos. Teratology 1994; 50:348-60.